Bilharzial vs non-bilharzial related bladder cancer: Pathological characteristics and value of cyclooxygenase-2 expression

BJU International

Volumn 108, Issue 1, 2011, Pages 31-37

  Youssef, Ramy ^a   Kapur, Payal ^b   Kabbani, Wareef ^b   Shariat, Shahrokh F ^d   Mosbah, Ahmed ^c   Abol Enein, Hassan ^c   Ghoniem, Mohamed ^c   Lotan, Yair ^a,e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MANSOURA UNIVERSITY   (Egypt)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e Southwestern Department of Urology   (United States)

Author keywords

Bilharzial bladder cancer; Bladder cancer markers; COX 2; squamous cell carcinoma of the bladder

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CYSTECTOMY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHISTOSOMIASIS;

ADULT; AGED; ANIMALS; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; CYSTECTOMY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 79959311343     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09854.x     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49
2. Fedewa SA, Soliman AS, Ismail K, et al. Incidence analyses of bladder cancer in the Nile delta region of Egypt. Cancer Epidemiol 2009; 33: 176-81
3. Michaud DS,. Chronic inflammation and bladder cancer. Urol Oncol 2007; 25: 260-8 (Pubitemid 46670749)
4. El-Sebaie M, Zaghloul MS, Howard G, Mokhtar A,. Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management. Int J Clin Oncol 2005; 10: 20-5 (Pubitemid 40379490)
5. Shokeir AA,. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int 2004; 93: 216-20
6. Ghoneim MA,. Bilharziasis of the genitourinary tract. BJU Int 2002; 89 (Suppl. 1): 22-30 (Pubitemid 34227050)
7. Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T,. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. APMIS 2009; 117: 45-52
8. Muller-Decker K, Furstenberger G,. The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis. Mol Carcinog 2007; 46: 705-10 (Pubitemid 47255191)
9. Pereg D, Lishner M,. Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer. J Intern Med 2005; 258: 115-23 (Pubitemid 41025968)
10. Pruthi RS, Derksen E, Gaston K, Wallen EM,. Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer. Urology 2004; 64: 637-42 (Pubitemid 39446031)
11. Cao Y, Prescott SM,. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 2002; 190: 279-86 (Pubitemid 34111968)
12. Hammam OA, Aziz AA, Roshdy MS, Abdel Hadi AM,. Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer. Medscape J Med 2008; 10: 60
13. Margulis V, Shariat SF, Ashfaq R, et al. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. J Urol 2007; 177: 1163-8 (Pubitemid 46216369)
14. Wadhwa P, Goswami AK, Joshi K, Sharma SK,. Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder. Int Urol Nephrol 2005; 37: 47-53 (Pubitemid 41236242)
15. Li G, Yang T, Li L, et al,. Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma. Colloids Surf B Biointerfaces 2004; 37: 15-9 (Pubitemid 39164189)
16. Shariat SF, Matsumoto K, Kim J, et al. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. J Urol 2003; 170: 985-9 (Pubitemid 36999617)
17. Shariat SF, Kim JH, Ayala GE, Kho K, Wheeler TM, Lerner SP,. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. J Urol 2003; 169: 938-42 (Pubitemid 36188129)
18. Shirahama T, Arima J, Akiba S, Sakakura C,. Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer 2001; 92: 188-93 (Pubitemid 32623056)
19. 19, El-Sheikh SS, Madaan S, Alhasso A, Abel P, Stamp G, Lalani EN,. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer. BJU Int 2001; 88: 921-7 (Pubitemid 34099020)
20. Wang D, Dubois RN,. Prostaglandins and cancer. Gut 2006; 55: 115-22 (Pubitemid 41820645)
21. Shariat SF, Chade DC, Karakiewicz PI, et al,. Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J Urol 2010; 183: 68-75
22. Shariat SF, Bolenz C, Godoy G, et al. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy. J Urol 2009; 182: 78-84; discussion
23. Shariat SF, Karakiewicz PI, Ashfaq R, et al,. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 2008; 112: 315-25
24. Shariat SF, Zlotta AR, Ashfaq R, Sagalowsky AI, Lotan Y,. Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness. Mod Pathol 2007; 20: 445-59 (Pubitemid 46482368)
25. Ghoneim MA, Abdel-Latif M, el-Mekresh M, et al,. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 2008; 180: 121-7
26. Rogers CG, Palapattu GS, Shariat SF, et al,. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol 2006; 175: 2048-53; discussion 2053 (Pubitemid 43668580)
27. Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE,. Aspirin intake and survival after breast cancer. J Clin Oncol 2010; 28: 1467-72